BlackRock Inc. - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 131 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$54,165,010
+21.7%
3,118,308
-1.3%
0.00%
+100.0%
Q2 2023$44,498,769
+22.1%
3,160,424
-6.7%
0.00%0.0%
Q1 2023$36,435,081
-32.1%
3,386,160
-5.5%
0.00%
-50.0%
Q4 2022$53,653,551
+15.2%
3,581,679
-1.3%
0.00%0.0%
Q3 2022$46,589,000
+36.0%
3,628,460
+2.6%
0.00%
+100.0%
Q2 2022$34,259,000
-1.4%
3,535,357
+1.2%
0.00%0.0%
Q1 2022$34,734,000
-15.3%
3,494,325
+0.3%
0.00%0.0%
Q4 2021$41,007,000
+15.4%
3,483,852
+11.7%
0.00%0.0%
Q3 2021$35,540,000
+2.1%
3,120,322
+24.8%
0.00%0.0%
Q2 2021$34,815,000
-16.4%
2,499,290
+11.0%
0.00%0.0%
Q1 2021$41,657,000
+7.7%
2,250,611
+2.8%
0.00%0.0%
Q4 2020$38,684,000
+38.0%
2,189,230
+19.7%
0.00%0.0%
Q3 2020$28,028,000
-8.1%
1,829,519
+52.9%
0.00%0.0%
Q2 2020$30,495,000
+111.1%
1,196,820
+28.3%
0.00%0.0%
Q1 2020$14,443,000
+37.7%
933,013
-1.6%
0.00%
Q4 2019$10,490,000
+10.3%
948,457
-15.2%
0.00%
Q3 2019$9,513,000
-36.5%
1,117,919
+1.0%
0.00%
-100.0%
Q2 2019$14,990,000
-14.3%
1,107,091
+14.4%
0.00%0.0%
Q1 2019$17,482,000
-3.5%
968,019
+50.1%
0.00%0.0%
Q4 2018$18,120,000
+57.7%
645,111
+43.2%
0.00%
Q3 2018$11,489,000
+6541.0%
450,573
+4405.7%
0.00%
Q2 2018$173,00010,0000.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q2 2023
NameSharesValueWeighting ↓
Spearhead Capital Advisors, LLC 202,580$2,601,0002.82%
Lion Point Capital, LP 480,000$5,140,0001.13%
HHLR ADVISORS, LTD. 2,920,023$37,493,0000.99%
TANG CAPITAL MANAGEMENT LLC 600,000$7,704,0000.94%
Rubric Capital Management LP 1,446,107$18,568,0000.94%
AlphaCentric Advisors LLC 43,000$552,0000.57%
RICE HALL JAMES & ASSOCIATES, LLC 749,933$9,629,0000.56%
Parkman Healthcare Partners LLC 126,192$1,620,0000.46%
Birchview Capital, LP 30,000$385,0000.27%
Baker Brothers Advisors 2,799,577$35,947,0000.24%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders